Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.

S M Rao1, G J Leo, L Bernardin

  • 1Department of Neurology, Medical College of Wisconsin, Milwaukee 53226.

Neurology
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metrics.

European journal of neurology·2020
Same author

Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.

European journal of neurology·2020
Same author

Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.

Journal of neurovirology·2018
Same author

Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.

Journal of neuroimmunology·2018
Same author

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Same author

Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.

Multiple sclerosis international·2014
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Cognitive dysfunction affects 43% of multiple sclerosis (MS) patients in the community, impacting memory and attention. A brief screening tool accurately identifies MS-related cognitive impairment.

Area of Science:

  • Neuroscience
  • Clinical Psychology

Background:

  • Previous estimates of cognitive dysfunction in multiple sclerosis (MS) range from 54-65%, potentially overestimating prevalence due to clinic-based recruitment.
  • Community-based studies are crucial for understanding the true frequency of cognitive impairment in the general MS population.

Purpose of the Study:

  • To determine the frequency and pattern of cognitive dysfunction in a community-based sample of MS patients.
  • To develop and validate a brief screening tool for MS-related cognitive impairment.

Main Methods:

  • A comprehensive neuropsychological test battery was administered to 100 community-based MS patients and 100 healthy controls.
  • A brief screening battery was developed using the four most sensitive cognitive test indices from the comprehensive battery.

Related Experiment Videos

Main Results:

  • Overall cognitive dysfunction was identified in 43% of the MS group, with impairments most common in recent memory, sustained attention, verbal fluency, conceptual reasoning, and visuospatial perception.
  • The brief screening battery demonstrated high accuracy, with a sensitivity of 71% and specificity of 94% in identifying MS patients with cognitive impairment.
  • Cognitive impairment showed a weak correlation with physical disability but was not significantly associated with illness duration, depression, disease course, or medication.

Conclusions:

  • Cognitive dysfunction is prevalent in community-based MS patients, with a distinct pattern of deficits.
  • A brief, empirically developed screening tool can effectively identify cognitive impairment in MS patients, aiding in early detection and management.